Evaxion Biotech Gets FDA Approval To Proceed With Clinical Phase 2b Study For EVX-01

RTTNews | 856 hari yang lalu
Evaxion Biotech Gets FDA Approval To Proceed With Clinical Phase 2b Study For EVX-01

(RTTNews) - Biotech company Evaxion Biotech A/S (EVAX) announced Tuesday that the U.S. Food and Drug Administration or FDA, determined that the Company may proceed with its Phase 2b clinical trial of EVX-01.

In November 2022, the Company submitted an Investigational New Drug Application along with a Fast Track designation application to the FDA for a Phase 2b clinical trial of EVX-01 in combination with KEYTRUDA for the treatment of patients with metastatic melanoma.

On December 22, 2022, the FDA issued approval for the Company to proceed with its Phase 2b trial. The Company anticipates a response to the Fast Track designation submission in the first quarter of 2023.

EVX-01 is already actively enrolling patients in Australia, and the FDA approval expands our ability to move forward quickly with our lead program in malignant melanoma.

The Phase 2b study will be conducted at clinical sites across the United States, Europe, and Australia. It is carried out in collaboration with Merck, supplying its PD-1 inhibitor KEYTRUDA. The trial was first initiated in Australia with the enrollment of the first patient in September 2022.

read more
Swiss Market Ends Moderately Lower

Swiss Market Ends Moderately Lower

After a positive start and a subsequent mild setback, the Switzerland market recovered and stayed firm till a little past mid afternoon on Thursday, but turned weak and ended the day's session moderately lower. Investors digested the monetary policy moves of the Federal Reserve and the Bank of England, and reports about the U.S. and the U.K. striking a trade deal.
RTTNews | 3j 53min yang lalu
European Stocks Close On Firm Note On Easing Trade Tensions

European Stocks Close On Firm Note On Easing Trade Tensions

European stocks closed on a firm note on Thursday with investors reacting to earnings, and news about an impending trade deal between the U.S. and the U.K., and digesting the Bank of England and the Federal Reserve's monetary policy moves.
RTTNews | 4j 13min yang lalu
U.S. Wholesale Inventories Climb Slightly Less Than Expected In March

U.S. Wholesale Inventories Climb Slightly Less Than Expected In March

The Commerce Department released a report on Thursday showing wholesale inventories in U.S. increased by slightly less than expected in the month of March. The report said wholesale inventories rose by 0.4 percent in March after climbing by an upwardly revised 0.5 percent in February.
RTTNews | 6j 33min yang lalu
U.S. Labor Productivity Decreases For First Time Since 2022

U.S. Labor Productivity Decreases For First Time Since 2022

The Labor Department released a report on Thursday showing a pullback by U.S. labor productivity in the first quarter of 2025 along with a sharp increase by unit labor costs. The report said labor productivity fell by 0.8 percent in the first quarter after jumping by an upwardly revised 1.7 percent in the fourth quarter of 2024.
RTTNews | 7j 7min yang lalu
U.S. Weekly Jobless Claims Dip Slightly More Than Expected

U.S. Weekly Jobless Claims Dip Slightly More Than Expected

First-time claims for U.S. unemployment benefits saw a modest decline in the week ended May 3rd, according to a report released by the Labor Department on Thursday. The report said initial jobless claims dipped to 228,000, a decrease of 13,000 from the previous week's unrevised level of 241,000. Economists had expected jobless claims to slip to 230,000.
RTTNews | 7j 12min yang lalu